• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿萨姆邦一家三级护理医院新冠重症监护病房在新冠疫情第一波和第二波期间收治患者的临床人口统计学特征比较

Comparison of the Clinico-Demographic Profile of Patients Admitted to the COVID ICU of a Tertiary Care Hospital in Assam During the First and Second Waves of the COVID-19 Pandemic.

作者信息

Saikia Dimpymoni, Das Basanta B, Borah Pollov, Das Bishnu R

机构信息

Community Medicine, Jorhat Medical College, Jorhat, IND.

Anesthesiology and Critical Care, Lakhimpur Medical College and Hospital, North Lakhimpur, IND.

出版信息

Cureus. 2025 May 30;17(5):e85090. doi: 10.7759/cureus.85090. eCollection 2025 May.

DOI:10.7759/cureus.85090
PMID:40585741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12206454/
Abstract

BACKGROUND

With the passage of time, COVID-19 strains have mutated, leading to newer strains, and reports are there on the differences in presentation, severity, and infectivity of COVID-19 in the first two waves of the pandemic.

OBJECTIVE

Comparison of the clinico-demographic profile and outcomes of patients admitted to the COVID ICU during the first and second waves.

MATERIALS AND METHODS

A hospital-based cross-sectional study was conducted for a period of six months among patients admitted to the COVID ICU of Jorhat Medical College and Hospital, a tertiary care hospital in Assam, including 284 patients. Data were collected from bed head tickets available in the Medical Records Department office. The t-test and χ2 test were used to compare data between the two waves.

RESULTS

In the first wave, most of the patients were 60 years and above, while in the second wave, the majority of cases were between 40 and 60 years (χ= 13.002, = 0.011). The presenting symptoms and the type of co-morbidities were similar in both waves. Mean delay in testing and hospitalization was significantly more in the second wave (= 0.005 and 0.02, respectively). Requirement of high flow O therapy (= 0.006) and ventilatory support (= 0.03) was higher in the second wave. The treatment protocol remained the same in both waves, except for universal use of remdesivir and decreased plasma therapy use in the second wave. The mean duration of hospital stay was longer in the second wave (= 0.02). There was a decrease in deaths from 42.1% to 36.1%, while discharges against medical advice increased from 2.1% to 12.5%.

CONCLUSIONS

The data of the study gave us an insight into the changes and similarities of the two waves. Understanding the disease at the local level can help us be better prepared in case of any further recurrence of the pandemic.

摘要

背景

随着时间的推移,新冠病毒毒株发生了变异,产生了新的毒株,且有关于新冠疫情前两波中新冠病毒在临床表现、严重程度和传染性方面差异的报道。

目的

比较第一波和第二波疫情期间入住新冠重症监护病房患者的临床人口统计学特征及结局。

材料与方法

在阿萨姆邦一家三级护理医院乔哈特医学院医院的新冠重症监护病房收治的患者中进行了为期六个月的基于医院的横断面研究,共纳入284例患者。数据从病历科办公室的床头卡中收集。采用t检验和χ²检验比较两波疫情期间的数据。

结果

在第一波疫情中,大多数患者年龄在60岁及以上,而在第二波疫情中,大多数病例年龄在40至60岁之间(χ = 13.002,P = 0.011)。两波疫情中的首发症状和合并症类型相似。第二波疫情中检测和住院的平均延迟时间显著更长(分别为P = 0.005和0.02)。第二波疫情中高流量吸氧治疗(P = 0.006)和通气支持(P = 0.03)的需求更高。两波疫情中的治疗方案基本相同,只是第二波疫情中普遍使用了瑞德西韦且血浆治疗的使用减少。第二波疫情中平均住院时间更长(P = 0.02)。死亡率从42.1%降至36.1%,而自动出院率从2.1%升至12.5%。

结论

该研究数据让我们深入了解了两波疫情的变化与相似之处。在地方层面了解该疾病有助于我们在疫情再次出现时做好更充分的准备。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda4/12206454/d28d266836be/cureus-0017-00000085090-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda4/12206454/d28d266836be/cureus-0017-00000085090-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda4/12206454/d28d266836be/cureus-0017-00000085090-i01.jpg

相似文献

1
Comparison of the Clinico-Demographic Profile of Patients Admitted to the COVID ICU of a Tertiary Care Hospital in Assam During the First and Second Waves of the COVID-19 Pandemic.阿萨姆邦一家三级护理医院新冠重症监护病房在新冠疫情第一波和第二波期间收治患者的临床人口统计学特征比较
Cureus. 2025 May 30;17(5):e85090. doi: 10.7759/cureus.85090. eCollection 2025 May.
2
Outcomes of pregnant ICU patients with severe COVID-19 pneumonia in Qatar during the three waves of the COVID-19 pandemic: A retrospective cohort study.卡塔尔新冠疫情三波期间重症新冠肺炎孕妇ICU患者的结局:一项回顾性队列研究
Qatar Med J. 2025 Feb 26;2025(1):12. doi: 10.5339/qmj.2025.12. eCollection 2025.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Antibiotics for exacerbations of asthma.用于哮喘加重期的抗生素
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
8
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.伊立替康、奥沙利铂和雷替曲塞用于治疗晚期结直肠癌:系统评价与经济学评估
Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150.

本文引用的文献

1
Evolution and major changes of the diagnosis and treatment protocol for COVID-19 patients in China 2020-2023.2020 - 2023年中国新冠病毒肺炎患者诊疗方案的演变及主要变化
Health Care Sci. 2023 May 17;2(3):135-152. doi: 10.1002/hcs2.45. eCollection 2023 Jun.
2
The Second- vs First-wave COVID-19: More of the Same or a Lot Worse? A Comparison of Mortality between the Two Waves in Patients Admitted to Intensive Care Units in Nine Hospitals in Western Maharashtra.新冠疫情第二波与第一波:情况相同还是更糟?马哈拉施特拉邦西部九家医院重症监护病房收治的两波患者死亡率比较
Indian J Crit Care Med. 2021 Dec;25(12):1343-1348. doi: 10.5005/jp-journals-10071-24042.
3
Urban to rural COVID-19 progression in India: The role of massive migration and the challenge to India's traditional labour force policies.
印度城市到农村的 COVID-19 疫情进展:大规模移民的作用和对印度传统劳动力政策的挑战。
Int J Health Plann Manage. 2022 Jan;37(1):528-535. doi: 10.1002/hpm.3327. Epub 2021 Sep 14.
4
Implications of the second wave of COVID-19 in India.新冠疫情第二波在印度的影响
Lancet Respir Med. 2021 Sep;9(9):e93-e94. doi: 10.1016/S2213-2600(21)00312-X. Epub 2021 Jun 30.
5
Differences between First wave and Second wave of COVID-19 in India.印度新冠疫情第一波和第二波之间的差异。
Diabetes Metab Syndr. 2021 May-Jun;15(3):1047-1048. doi: 10.1016/j.dsx.2021.05.009. Epub 2021 May 8.
6
First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain.新冠肺炎疫情的第一波和第二波:西班牙雷乌斯住院患者的对比研究。
PLoS One. 2021 Mar 31;16(3):e0248029. doi: 10.1371/journal.pone.0248029. eCollection 2021.
7
Epidemiologic comparison of the first and second waves of coronavirus disease in Babol, North of Iran.伊朗北部巴博勒市新冠病毒疾病第一波和第二波的流行病学比较
Caspian J Intern Med. 2020 Fall;11(Suppl 1):544-550. doi: 10.22088/cjim.11.0.544.
8
Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain.与 SARS-CoV-2 感染住院患者死亡率相关的危险因素。一项在西班牙雷乌斯进行的前瞻性、纵向、单中心研究。
PLoS One. 2020 Sep 3;15(9):e0234452. doi: 10.1371/journal.pone.0234452. eCollection 2020.
9
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
10
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情,该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.